Hefei Lifeon Pharmaceutical Hits Day High with 9.98% Surge

Hefei Lifeon Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 9.98% on July 13, 2026. The stock reached an intraday high of CNY 20.61, marking a notable performance against the backdrop of a declining China Shanghai Composite, which fell by 2.06% on the same day. Over the past week, Hefei Lifeon has shown impressive growth, with a 25.82% increase, while its one-month performance stands at 32.8%. However, the company has faced challenges in the longer term, with a one-year performance of 7.06%, which lags behind the China Shanghai Composite's 11.5%. Despite the recent uptick, Hefei Lifeon has reported negative results for the last six consecutive quarters, and its net sales have declined at an annual rate of 4.87% over the past five years. The company’s market capitalization is CNY 2,624 million, and it operates within the pharmaceuticals and biotechnology sector. Key financial metrics include a P/E ratio of 16.00 and a dividend yield of 2.18%.